Articles

Patient safety and ensuring compliance with regulations – including FDA Current Good Manufacturing Practice (CGMP) and 21 CFR part 11 – are the top priorities in the pharmaceutical industry. The industry is also facing a range of other issues,...

Many players in the pharma industry are making investments in digital solutions in order to enhance their calibration processes. But how can you make sure these investments pay off and do not negatively affect compliance or patient safety? An...

Recent trends in the research-based pharmaceuticals industry, including personalized medicine, flexible production facilities, and digitalization are impacting established processes and requiring new ways of thinking. For example, personalized medicine –treatment targeted to the individual based on a specific patient diagnosis...

Today, within the pandemic situation, mRNA or gene therapy is no longer unknown to us. Whether you are a gardener, computer engineer, or dentist, we have all received an accelerated course on how biologics are manufactured. This real-life situation...

In the IDC Info Brief: "Good Manufacturing Practices for Asia/Pacific Pharmaceutical Companies: Accelerating Transformation with Manufacturing 4.0” published in June 2021 and sponsored by Cognizant and Zenith, IDC analysts found organizations in Asia are working on their Industry 4.0...

Being aware that maintenance has a big influence on both compliance of pharmaceutical processes and the quality of products, observant business owners are beginning to realize the undeniable advantages of controlling and planning maintenance with a Computerized Maintenance Management...

Impact of COVID-19 on Biopharma CDMO Market: Innovation and Investment The COVID-19 pandemic has strained resources across the globe and impacted nearly every sector. Arguably, it has been most acutely felt in the pharmaceutical space. While many drug developers and manufacturers...